Table 3.
PROBANDS | AR IEI | XLR IEI | AD IEI | TOTAL |
---|---|---|---|---|
Probands with LP/P variant on panel | 4 (3 homozygous; 1 compound heterozygous) | 5 (hemizygous males) | 3 (heterozygous) | 12 |
Probands with LP/P variant on WES | 6 (homozygous or compound heterozygous) | 3 (hemizygous males) | 3 (heterozygous) | 12 |
Probands total | 10 (homozygous or compound heterozygous) | 8 (hemizygous males) | 6 (heterozygous) | 24 |
FAMILY MEMBERS | AR IEI | XLR IEI | AD IEI | TOTAL |
Family members identified as carriers | 20 (either through testing or known obligate carrier) | 8* (heterozygous females) | 0 | 28 |
Family member excluded as carriers/affected | n/a | 1 (maternal aunt of proband) | 6* | 7 |
*All were parents of probands.
VUS, variant of unknown significance; WES, whole exome sequencing; AR, autosomal recessive; XLR, X-linked recessive; AD, autosomal dominant; LP/P, likely pathogenic/pathogenic; IEI, inborn error of immunity.